Frequently Asked Questions
The market is segmented based on , By Product Type (Software, Devices, and Consumables and Accessories), Technology (Volume Measurement Spirometer, Flow Measurement Spirometer, and Peak Flow Meter), Mechanism (Flow-Sensing Spirometer and Peak Flow Meters), Disease (Bronchitis, Emphysema, Chronic Obstructive Lung Disease, Lung Cancer, and Others), Disposable Components (Filters, Sensors, and Tubes), Application (Asthma, COPD, Cystic Fibrosis, Pulmonary Fibrosis, and Others), End-User (Hospitals, Clinics, and Homecare), Distribution Channel (Over the Counter and Direct Tender) – Industry Trends and Forecast to 2031.
.
The Global Spirometer Market size was valued at USD 789.04 USD Million in 2023.
The Global Spirometer Market is projected to grow at a CAGR of 10.9% during the forecast period of 2024 to 2031.
The major players operating in the market include F. Hoffmann-La Roche, Ltd. (Switzerland), Mylan N.V. (U.S.), Sanofi (France), Pfizer Inc. (U.S.), GSK plc. (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Merck & Co. Inc. (U.S.), AstraZeneca (U.K.), Cipla (U.S.) , Merck KGaA (Germany), LEO Pharma A/S (Denmark), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Fresenius Kabi AG (Germany), and Amneal Pharmaceuticals LLC. (U.S.).
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
